84 related articles for article (PubMed ID: 22400713)
1. Structure-activity relationships and optimization of 3,5-dichloropyridine derivatives as novel P2X(7) receptor antagonists.
Lee WG; Lee SD; Cho JH; Jung Y; Kim JH; Hien TT; Kang KW; Ko H; Kim YC
J Med Chem; 2012 Apr; 55(8):3687-98. PubMed ID: 22400713
[TBL] [Abstract][Full Text] [Related]
2. Discovery of novel purine-based heterocyclic P2X7 receptor antagonists.
Kwak SH; Lee WG; Lee YJ; Lee SD; Kim YC; Ko H
Bioorg Chem; 2015 Aug; 61():58-65. PubMed ID: 26123174
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship studies of pyrimidine-2,4-dione derivatives as potent P2X7 receptor antagonists.
Park JH; Lee GE; Lee SD; Ko H; Kim YC
Eur J Med Chem; 2015 Dec; 106():180-93. PubMed ID: 26547056
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and structure-activity relationships of quinolinone and quinoline-based P2X7 receptor antagonists and their anti-sphere formation activities in glioblastoma cells.
Kwak SH; Shin S; Lee JH; Shim JK; Kim M; Lee SD; Lee A; Bae J; Park JH; Abdelrahman A; Müller CE; Cho SK; Kang SG; Bae MA; Yang JY; Ko H; Goddard WA; Kim YC
Eur J Med Chem; 2018 May; 151():462-481. PubMed ID: 29649742
[TBL] [Abstract][Full Text] [Related]
5. Characterization of protoberberine analogs employed as novel human P2X7 receptor antagonists.
Lee GE; Lee WG; Lee SY; Lee CR; Park CS; Chang S; Park SG; Song MR; Kim YC
Toxicol Appl Pharmacol; 2011 Apr; 252(2):192-200. PubMed ID: 21320518
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and structure-activity relationships of pyrazolodiazepine derivatives as human P2X7 receptor antagonists.
Lee JY; Yu J; Cho WJ; Ko H; Kim YC
Bioorg Med Chem Lett; 2009 Nov; 19(21):6053-8. PubMed ID: 19800793
[TBL] [Abstract][Full Text] [Related]
7. Discovery of novel 2,5-dioxoimidazolidine-based P2X(7) receptor antagonists as constrained analogues of KN62.
Park JH; Lee GE; Lee SD; Hien TT; Kim S; Yang JW; Cho JH; Ko H; Lim SC; Kim YG; Kang KW; Kim YC
J Med Chem; 2015 Mar; 58(5):2114-34. PubMed ID: 25597334
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and SAR development of novel P2X7 receptor antagonists for the treatment of pain: part 2.
Brumfield S; Matasi JJ; Tulshian D; Czarniecki M; Greenlee W; Garlisi C; Qiu H; Devito K; Chen SC; Sun Y; Bertorelli R; Ansell J; Geiss W; Le VD; Martin GS; Vellekoop SA; Haber J; Allard ML
Bioorg Med Chem Lett; 2011 Dec; 21(24):7287-90. PubMed ID: 22078214
[TBL] [Abstract][Full Text] [Related]
9. Effect of Rheedia longifolia leaf extract and fractions on the P2X₇ receptor in vitro: novel antagonists?
Santos JA; Fidalgo-Neto AA; Faria RX; Simões A; Calheiros AS; Bérenger AL; Faria-Neto HC; Figueiredo MR; Frutuoso VS; Alves LA
J Med Food; 2011 Sep; 14(9):920-9. PubMed ID: 21554119
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure-activity relationships of carboxylic acid derivatives of pyridoxal as P2X receptor antagonists.
Jung KY; Cho JH; Lee JS; Kim HJ; Kim YC
Bioorg Med Chem; 2013 May; 21(9):2643-50. PubMed ID: 23510563
[TBL] [Abstract][Full Text] [Related]
11. Murine epidermal Langerhans cells and keratinocytes express functional P2X7 receptors.
Tran JN; Pupovac A; Taylor RM; Wiley JS; Byrne SN; Sluyter R
Exp Dermatol; 2010 Aug; 19(8):e151-7. PubMed ID: 20113349
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationship studies on a series of novel, substituted 1-benzyl-5-phenyltetrazole P2X7 antagonists.
Nelson DW; Gregg RJ; Kort ME; Perez-Medrano A; Voight EA; Wang Y; Grayson G; Namovic MT; Donnelly-Roberts DL; Niforatos W; Honore P; Jarvis MF; Faltynek CR; Carroll WA
J Med Chem; 2006 Jun; 49(12):3659-66. PubMed ID: 16759108
[TBL] [Abstract][Full Text] [Related]
13. Discovery and structure-activity relationships of a series of pyroglutamic acid amide antagonists of the P2X7 receptor.
Abdi MH; Beswick PJ; Billinton A; Chambers LJ; Charlton A; Collins SD; Collis KL; Dean DK; Fonfria E; Gleave RJ; Lejeune CL; Livermore DG; Medhurst SJ; Michel AD; Moses AP; Page L; Patel S; Roman SA; Senger S; Slingsby B; Steadman JG; Stevens AJ; Walter DS
Bioorg Med Chem Lett; 2010 Sep; 20(17):5080-4. PubMed ID: 20673717
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationships of novel, substituted 5,6-dihydrodibenzo[a,g]quinolizinium P2X7 antagonists.
Lee GE; Lee HS; Lee SD; Kim JH; Kim WK; Kim YC
Bioorg Med Chem Lett; 2009 Feb; 19(3):954-8. PubMed ID: 19110420
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
[TBL] [Abstract][Full Text] [Related]
16. Discovery, synthesis and SAR of azinyl- and azolylbenzamides antagonists of the P2X₇ receptor.
Subramanyam C; Duplantier AJ; Dombroski MA; Chang SP; Gabel CA; Whitney-Pickett C; Perregaux DG; Labasi JM; Yoon K; Shepard RM; Fisher M
Bioorg Med Chem Lett; 2011 Sep; 21(18):5475-9. PubMed ID: 21782426
[TBL] [Abstract][Full Text] [Related]
17. Tanshinone II A sulfonate, but not tanshinone II A, acts as potent negative allosteric modulator of the human purinergic receptor P2X7.
Kaiser M; Sobottka H; Fischer W; Schaefer M; Nörenberg W
J Pharmacol Exp Ther; 2014 Sep; 350(3):531-42. PubMed ID: 24970925
[TBL] [Abstract][Full Text] [Related]
18. Modulation of monocyte signaling and pore formation in response to agonists of the nucleotide receptor P2X(7).
Aga M; Johnson CJ; Hart AP; Guadarrama AG; Suresh M; Svaren J; Bertics PJ; Darien BJ
J Leukoc Biol; 2002 Jul; 72(1):222-32. PubMed ID: 12101284
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of potent and selective P2X₃ receptor antagonists derived from PPADS as potential pain modulators.
Cho JH; Jung KY; Jung Y; Kim MH; Ko H; Park CS; Kim YC
Eur J Med Chem; 2013; 70():811-30. PubMed ID: 24246730
[TBL] [Abstract][Full Text] [Related]
20. 1,4-Naphthoquinones potently inhibiting P2X7 receptor activity.
Faria RX; Oliveira FH; Salles JP; Oliveira AS; von Ranke NL; Bello ML; Rodrigues CR; Castro HC; Louvis AR; Martins DL; Ferreira VF
Eur J Med Chem; 2018 Jan; 143():1361-1372. PubMed ID: 29133043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
